Natural History of Imatinib-naive GISTs

Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size

(2010) Sabrina Rossi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

BRAFMutation Status in Gastrointestinal Stromal Tumors

(2009) Isabelle Hostein et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Gastrointestinal Stromal Tumors Presenting as Omental Masses—A Clinicopathologic Analysis of 95 Cases

(2009) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

(2009) A Agaimy et al.   JOURNAL OF CLINICAL PATHOLOGY

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

(2009) Jason S Gold et al.   LANCET ONCOLOGY

Multiple Primary Sporadic Gastrointestinal Stromal Tumors in the Adult: An Underestimated Entity

(2008) D. Gasparotto et al.   CLINICAL CANCER RESEARCH

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

(2008) Narasimhan P. Agaram et al.   GENES CHROMOSOMES & CANCER

Risk stratification of patients diagnosed with gastrointestinal stromal tumor

(2008) Heikki Joensuu   HUMAN PATHOLOGY

How To Build and Interpret a Nomogram for Cancer Prognosis

(2008) Alexia Iasonos et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)

(2007) Ronald P. DeMatteo et al.   CANCER